Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6383)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 28, 2023 (publication date) through May 20, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jiang SW, Lian X, Hu AR, Lu JL, He ZY, Shi XJ, Zhu DD, Wang ZY, Huang GC. Liver histopathological lesions is severe in patients with normal alanine transaminase and low to moderate hepatitis B virus DNA replication. World J Gastroenterol 2023; 29(16): 2479-2494 [PMID: 37179582 DOI: 10.3748/wjg.v29.i16.2479] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i16/2479.htm |
| Number | Citing Articles |
| 1 |
Romaric De Manfouo Tuono, Marius Mbiandjeu Tchoumke, Winy Asdrid Djoumeni Tepe, Winnie Ketcha Jeuta, Simon Ngamli Fewou. Plasminogen as a Marker for Assessing Thrombotic Risk During Hepatitis in Cameroon: Case–Control Study. Health Science Reports 2025; 8(4) doi: 10.1002/hsr2.70648
|
| 2 |
Chih-Lin Lin, Jia-Horng Kao. Should we expand treatment initiation criteria for chronic HBV infection: Pros. Clinical Liver Disease 2024; 23(1) doi: 10.1097/CLD.0000000000000228
|
| 3 |
Yen-Chun Liu, Wen-Juei Jeng. Should Indications for Antiviral Therapy for Hepatitis B Be Broadened to Include Immune-Tolerant Patients, Inactive Carriers, or Patients in the “Gray Zone”?. Current Hepatology Reports 2024; 23(1): 11 doi: 10.1007/s11901-024-00635-w
|
| 4 |
Yuanyuan Li, Yijia Zhu, Dongmei Gao, Yifan Pan, Jian Wang, Shaoqiu Zhang, Xiaomin Yan, Li Zhu, Chuanwu Zhu, Xingxiang Liu, Zhaoping Zhang, Jie Li, Yuxin Chen, Rui Huang, Chao Wu. HBeAg-positive CHB patients with indeterminate phase associated with a high risk of significant fibrosis. Virology Journal 2024; 21(1) doi: 10.1186/s12985-024-02561-1
|
| 5 |
静 张. Research Progress and Prospects of Chronic Hepatitis B Virus Infection in Gray Zone. Advances in Clinical Medicine 2024; 14(05): 689 doi: 10.12677/acm.2024.1451478
|
| 6 |
Xue-Yan Yang, Xi-Dong Li, Bai-Yun Wu, Qiao Yang, Yu-Bao Zheng, Ming-Hua Zheng, Yin-Ping Wu, Hang-Yu Ma, Jing Zuo, Ruo-Xi Jia, Yue Yu, Ling-Yun Xu, Yu-Xin Tian, Qi An, Tao Zhang, Ying-Li He, Yu Shi, Yu-Chen Fan. A Model to Identify Gray Zone Patients With Chronic Hepatitis B Requiring Antiviral Therapy: A Multicenter Retrospective Study. The Journal of Infectious Diseases 2025; doi: 10.1093/infdis/jiaf070
|
| 7 |
Haiyan Fu, Hongjuan Li, Yingrong Du, Chunyun Liu, Futao Dang, Xuan Zhang, Danqing Xu, Yachao Mao, Li Feng Wang, Yu Luo, Li Liu. Factors influencing pathological changes in the liver tissue in hepatitis B virus carriers with low-level viremia. Clinics and Research in Hepatology and Gastroenterology 2024; 48(7): 102351 doi: 10.1016/j.clinre.2024.102351
|
| 8 |
Su-Wen Jiang, Ai-Rong Hu. Further understanding of chronic hepatitis B in the indeterminate phase or in the grey zone. World Chinese Journal of Digestology 2024; 32(1): 8 doi: 10.11569/wcjd.v32.i1.8
|
| 9 |
Sana Rouis, soumaya mrabet, Mohamed Ferjaoui, Nedia Ben Lasfar, Jihene Sahli, Syrine Boujamline, Rym Ayari, Maha Abid, Manel Ben Selma, Mariem Ben Ticha, Foued Bellazreg, Elhem Ben Jezia, Amel Letaief, Wissem Hachfi. Factors Associated with Progressive Liver Disease in Untreated HBV patients in Tunisia. F1000Research 2025; 14: 11 doi: 10.12688/f1000research.157075.2
|
| 10 |
Ken Lin, Su-Wen Jiang, Ai-Rong Hu. Management of antiviral treatment for chronic hepatitis B patients with high viral load. World Chinese Journal of Digestology 2024; 32(9): 625 doi: 10.11569/wcjd.v32.i9.625
|
| 11 |
Feng Chen, Qianhui Li, Xiaomin Xu, Fei Wang. Non-invasive Diagnostic Indicators and Antiviral Treatment Efficacy in CHB Patients with Different Liver Histopathological Degrees. Hepatitis Monthly 2024; 24(1) doi: 10.5812/hepatmon-147016
|
| 12 |
Hang-Yu Ma, Xue-Yan Yang, Yu-Xin Tian, Xi-Dong Li, Ying-Li He, Qiao Yang, Ming-Hua Zheng, Yu-Bao Zheng, Yue Yu, Ling-Yun Xu, Qian-Nan Wang, Tao Zhang, Yu Shi, Yu-Chen Fan. Performance of the AASLD, EASL, and APASL Clinical Practice Guidelines in"grey zone"stages of Chinese patients with chronic hepatitis B. Hepatology International 2025; doi: 10.1007/s12072-025-10833-3
|
| 13 |
Sana Rouis, soumaya mrabet, Mohamed Ferjaoui, Nedia Ben Lasfar, Jihene Sahli, Syrine Boujamline, Rym Ayari, Maha Abid, Manel Ben Selma, Mariem Ben Ticha, Foued Bellazreg, Elhem Ben Jezia, Amel Letaief, Wissem Hachfi. Factors associated with progression of fibrosis in chronic hepatitis B virus infection in the indeterminate phase. F1000Research 2025; 14: 11 doi: 10.12688/f1000research.157075.1
|
| 14 |
Lei Ma, Hui-Chun Xing. Elimination of hepatitis B as a public health threat: Addressing the challenge and taking action. World Journal of Hepatology 2024; 16(11): 1361-1364 doi: 10.4254/wjh.v16.i11.1361
|